Literature DB >> 8670836

Truncated, desensitization-defective neurokinin receptors mediate sustained MAP kinase activation, cell growth and transformation by a Ras-independent mechanism.

J Alblas1, I van Etten, W H Moolenaar.   

Abstract

We have used the neurokinin NK-2 receptor as a model to examine how receptor desensitization affects cellular responses. The liganded receptor transiently activates phospholipase C (PLC) and is rapidly phosphorylated on Ser/Thr residues in its C-terminal domain. Mutant receptors lacking this domain mediate persistent activation of PLC. We now show that, in transfected Rat-1 cells, mutant receptor mediates ligand-induced DNA synthesis, morphological transformation and growth in soft agar, whereas wild-type (wt) receptor does not. Wt receptor causes only transient MAP kinase activation. In contrast, MAP kinase activation by mutant receptor is sustained for >4 h. Neither wt nor mutant receptor couples to Ras activation. Downregulation of protein kinase C (PKC) has little effect on MAP kinase activation, DNA synthesis and transformation. Mutant receptors also promote stronger protein tyrosine phosphorylation and stress fibre formation than does wt receptor. Thus, C-terminal truncation allows the NK-2 receptor to signal sustained MAP kinase activation, cell growth and transformation by a Ras- and PKC-independent mechanism. Our results reveal the importance of the C-terminal 'desensitization domain' in suppressing the oncogenic potential of a prototypic PLC-coupled receptor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8670836      PMCID: PMC451898     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  44 in total

Review 1.  Transmembrane receptors and intracellular pathways that control cell proliferation.

Authors:  J Pouysségur; K Seuwen
Journal:  Annu Rev Physiol       Date:  1992       Impact factor: 19.318

2.  Biphasic and synergistic activation of p44mapk (ERK1) by growth factors: correlation between late phase activation and mitogenicity.

Authors:  S Meloche; K Seuwen; G Pagès; J Pouysségur
Journal:  Mol Endocrinol       Date:  1992-05

Review 3.  G-protein-coupled receptors, phosphoinositide hydrolysis, and cell proliferation.

Authors:  W H Moolenaar
Journal:  Cell Growth Differ       Date:  1991-07

4.  Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes.

Authors:  J S Gutkind; E A Novotny; M R Brann; K C Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

5.  Regions of the alpha 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function.

Authors:  S Cotecchia; S Exum; M G Caron; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

6.  G-protein-coupled receptor genes as protooncogenes: constitutively activating mutation of the alpha 1B-adrenergic receptor enhances mitogenesis and tumorigenicity.

Authors:  L F Allen; R J Lefkowitz; M G Caron; S Cotecchia
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

7.  Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation.

Authors:  D Julius; T J Livelli; T M Jessell; R Axel
Journal:  Science       Date:  1989-06-02       Impact factor: 47.728

8.  Involvement of Ras and Raf in the Gi-coupled acetylcholine muscarinic m2 receptor activation of mitogen-activated protein (MAP) kinase kinase and MAP kinase.

Authors:  S Winitz; M Russell; N X Qian; A Gardner; L Dwyer; G L Johnson
Journal:  J Biol Chem       Date:  1993-09-15       Impact factor: 5.157

9.  Serum-induced membrane depolarization in quiescent fibroblasts: activation of a chloride conductance through the G protein-coupled LPA receptor.

Authors:  F R Postma; K Jalink; T Hengeveld; A G Bot; J Alblas; H R de Jonge; W H Moolenaar
Journal:  EMBO J       Date:  1996-01-02       Impact factor: 11.598

10.  Pertussis toxin-sensitive activation of p21ras by G protein-coupled receptor agonists in fibroblasts.

Authors:  E J van Corven; P L Hordijk; R H Medema; J L Bos; W H Moolenaar
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

View more
  6 in total

1.  The delta e13 isoform of the calcitonin receptor forms a six-transmembrane domain receptor with dominant-negative effects on receptor surface expression and signaling.

Authors:  Thomas Seck; Maria Pellegrini; Ana Maria Florea; Veronique Grignoux; Roland Baron; Dale F Mierke; William C Horne
Journal:  Mol Endocrinol       Date:  2005-04-28

2.  Transformation of breast cells by truncated neurokinin-1 receptor is secondary to activation by preprotachykinin-A peptides.

Authors:  Hiral J Patel; Shakti H Ramkissoon; Prem S Patel; Pranela Rameshwar
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-16       Impact factor: 11.205

3.  SR140333 counteracts NK-1 mediated cell proliferation in human breast cancer cell line T47D.

Authors:  Wei-Qing Huang; Ji-Gang Wang; Lei Chen; Hong-Jun Wei; Hua Chen
Journal:  J Exp Clin Cancer Res       Date:  2010-05-24

4.  beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2.

Authors:  K A DeFea; J Zalevsky; M S Thoma; O Déry; R D Mullins; N W Bunnett
Journal:  J Cell Biol       Date:  2000-03-20       Impact factor: 10.539

5.  Acute loss of cell-cell communication caused by G protein-coupled receptors: a critical role for c-Src.

Authors:  F R Postma; T Hengeveld; J Alblas; B N Giepmans; G C Zondag; K Jalink; W H Moolenaar
Journal:  J Cell Biol       Date:  1998-03-09       Impact factor: 10.539

6.  Regulation of connexin43 gap junctional communication by phosphatidylinositol 4,5-bisphosphate.

Authors:  Leonie van Zeijl; Bas Ponsioen; Ben N G Giepmans; Aafke Ariaens; Friso R Postma; Péter Várnai; Tamas Balla; Nullin Divecha; Kees Jalink; Wouter H Moolenaar
Journal:  J Cell Biol       Date:  2007-05-29       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.